Grassley mulls subpoenas for Mylan, DOJ over EpiPen

Grassley mulls subpoenas for Mylan, DOJ over EpiPen


The chairman of the Senate Judiciary Committee said Wednesday he is considering a subpoena or another method of compelling testimony from the pharmaceutical company Mylan, the Justice Department and the federal Centers for Medicare and Medicaid Services. Sen. Charles Grassley, R-Iowa, said in a statement that he is postponing the Nov. 30 hearing on a possible settlement between Mylan and the Justice Department over Mylan's life-saving EpiPen.



from Biotech News